Irina Esterlis Selected Research

Mental Disorders (Mental Disorder)

1/2023	Nicotine Use and Metabotropic Glutamate Receptor 5 in Individuals With Major Depressive and Posttraumatic Stress Disorders.
1/2023	The metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders.
1/2022	Lower synaptic density is associated with psychiatric and cognitive alterations in obesity.
1/2022	Imaging the effect of ketamine on synaptic density (SV2A) in the living brain.
11/2020	Measuring the effects of ketamine on mGluR5 using [18F]FPEB and PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irina Esterlis Research Topics

Disease

7	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023 - 01/2017
6	Major Depressive Disorder (Major Depressive Disorders) 01/2024 - 08/2012
5	Mental Disorders (Mental Disorder) 01/2023 - 11/2020
4	Wounds and Injuries (Trauma) 01/2023 - 01/2017
4	Schizophrenia (Dementia Praecox) 01/2018 - 03/2012
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2023 - 11/2013
3	Pain (Aches) 03/2013 - 12/2009
2	Mood Disorders (Mood Disorder) 01/2023 - 07/2016
2	Alcoholism (Alcohol Abuse) 01/2022 - 06/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024
1	Alzheimer Disease (Alzheimer's Disease) 02/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Obesity 01/2022
1	Cognitive Dysfunction 01/2021
1	Necrosis 01/2021
1	Inflammation (Inflammations) 10/2020
1	Tobacco Use Disorder (Nicotine Dependence) 01/2018
1	Treatment-Resistant Depressive Disorder 01/2016
1	Neuroinflammatory Diseases 10/2013
1	Body Weight (Weight, Body) 04/2013
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2011

Drug/Important Bio-Agent (IBA)

9	Metabotropic Glutamate 5 ReceptorIBA 01/2024 - 01/2017
8	Nicotine FDA Link 01/2023 - 04/2011
6	Glutamic Acid (Glutamate)FDA Link 01/2023 - 01/2017
6	Ketamine FDA LinkGeneric 01/2022 - 01/2016
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2014 - 05/2010
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 10/2013
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2020
3	gamma-Aminobutyric Acid (GABA)IBA 03/2013 - 12/2009
2	Cholinergic Agents (Cholinergics)IBA 07/2016 - 11/2013
2	GABA-A Receptors (GABA(A) Receptor)IBA 03/2013 - 12/2009
1	SAM-760IBA 02/2023
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	LipidsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	SmokeIBA 01/2018
1	GlucocorticoidsIBA 01/2017
1	ProteomeIBA 07/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	N-Methylaspartate (NMDA)IBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 09/2014
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2013

Therapy/Procedure

1	Self Medication 01/2018
1	Intravenous Administration 04/2013
1	Nebulizers and Vaporizers (Inhaler) 04/2011